ReP USP - Resultado da busca

Artigo de periodico
Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector (2017)
Esaki, Tamura Rodrigo; Hunger, Aline; Fernandes, Denise C.; Laurindo, Francisco R.; Costanzi-Strauss, Eugenia ; Strauss, Bryan E.
Source: Human Gene Therapy. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESAKI, Tamura Rodrigo et al. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector. Human Gene Therapy, v. 28, n. 8, p. 639-653, 2017Tradução . . Disponível em: https://doi.org/10.1089/hum.2016.139. Acesso em: 01 out. 2024.
APA
Esaki, T. R., Hunger, A., Fernandes, D. C., Laurindo, F. R., Costanzi-Strauss, E., & Strauss, B. E. (2017). Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector. Human Gene Therapy, 28( 8), 639-653. doi:10.1089/hum.2016.139
NLM
Esaki TR, Hunger A, Fernandes DC, Laurindo FR, Costanzi-Strauss E, Strauss BE. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector [Internet]. Human Gene Therapy. 2017 ; 28( 8): 639-653.[citado 2024 out. 01 ] Available from: https://doi.org/10.1089/hum.2016.139
Vancouver
Esaki TR, Hunger A, Fernandes DC, Laurindo FR, Costanzi-Strauss E, Strauss BE. Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector [Internet]. Human Gene Therapy. 2017 ; 28( 8): 639-653.[citado 2024 out. 01 ] Available from: https://doi.org/10.1089/hum.2016.139
Artigo de periodico
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy (2016)
Medrano, Ruan Felipe; Catani, João Paulo Portela; Ribeiro, Aline Hunger; Tomaz, Samanta Lopes; Merkel, Christian A; Costanzi-Strauss, Eugenia ; Strauss, Bryan Eric
Source: Cancer Immunology, Immunotherapy. Unidade: ICB
Subjects: IMUNOTERAPIA, MELANOMA, ADENOVÍRUS, VACINAÇÃO, TRANSFERÊNCIA DE GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDRANO, Ruan Felipe et al. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy. Cancer Immunology, Immunotherapy, v. 65, n. 4, p. 371-382, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00262-016-1807-8. Acesso em: 01 out. 2024.
APA
Medrano, R. F., Catani, J. P. P., Ribeiro, A. H., Tomaz, S. L., Merkel, C. A., Costanzi-Strauss, E., & Strauss, B. E. (2016). Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy. Cancer Immunology, Immunotherapy, 65( 4), 371-382. doi:10.1007/s00262-016-1807-8
NLM
Medrano RF, Catani JPP, Ribeiro AH, Tomaz SL, Merkel CA, Costanzi-Strauss E, Strauss BE. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy [Internet]. Cancer Immunology, Immunotherapy. 2016 ; 65( 4): 371-382.[citado 2024 out. 01 ] Available from: https://doi.org/10.1007/s00262-016-1807-8
Vancouver
Medrano RF, Catani JPP, Ribeiro AH, Tomaz SL, Merkel CA, Costanzi-Strauss E, Strauss BE. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy [Internet]. Cancer Immunology, Immunotherapy. 2016 ; 65( 4): 371-382.[citado 2024 out. 01 ] Available from: https://doi.org/10.1007/s00262-016-1807-8
Artigo de periodico
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma (2016)
Catani, João Paulo Portela; Medrano, Ruan Felipe Vieira; Ribeiro, Aline Hunger; Valle, Paulo Roberto Del; Adjemian, Sandy; Zanatta, Daniela Bertolini; Kroemer, Guido; Costanzi-Strauss, Eugenia ; Strauss, Bryan Eric
Source: Translational Oncology. Unidade: ICB
Subjects: CARCINOMA, TRANSFERÊNCIA DE GENES, IMUNIZAÇÃO, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATANI, João Paulo Portela et al. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology, v. 9, n. 6, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.tranon.2016.09.011. Acesso em: 01 out. 2024.
APA
Catani, J. P. P., Medrano, R. F. V., Ribeiro, A. H., Valle, P. R. D., Adjemian, S., Zanatta, D. B., et al. (2016). Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology, 9( 6). doi:10.1016/j.tranon.2016.09.011
NLM
Catani JPP, Medrano RFV, Ribeiro AH, Valle PRD, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma [Internet]. Translational Oncology. 2016 ; 9( 6):[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.tranon.2016.09.011
Vancouver
Catani JPP, Medrano RFV, Ribeiro AH, Valle PRD, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma [Internet]. Translational Oncology. 2016 ; 9( 6):[citado 2024 out. 01 ] Available from: https://doi.org/10.1016/j.tranon.2016.09.011
Artigo de periodico
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy (2016)
Tamura, Rodrigo Esaki; Soares, Rafael Bento da Silva; Costanzi-Strauss, Eugenia ; Strauss, Bryan Eric
Source: Cancer Biology & Therapy. Unidade: ICB
Subjects: ADENOVÍRUS, APOPTOSE, CARCINOMA, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMURA, Rodrigo Esaki et al. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy. Cancer Biology & Therapy, v. 17, n. 12, p. 1221-1230, 2016Tradução . . Disponível em: https://doi.org/10.1080/15384047.2016.1235655. Acesso em: 01 out. 2024.
APA
Tamura, R. E., Soares, R. B. da S., Costanzi-Strauss, E., & Strauss, B. E. (2016). Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy. Cancer Biology & Therapy, 17( 12), 1221-1230. doi:10.1080/15384047.2016.1235655
NLM
Tamura RE, Soares RB da S, Costanzi-Strauss E, Strauss BE. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy [Internet]. Cancer Biology & Therapy. 2016 ; 17( 12): 1221-1230.[citado 2024 out. 01 ] Available from: https://doi.org/10.1080/15384047.2016.1235655
Vancouver
Tamura RE, Soares RB da S, Costanzi-Strauss E, Strauss BE. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy [Internet]. Cancer Biology & Therapy. 2016 ; 17( 12): 1221-1230.[citado 2024 out. 01 ] Available from: https://doi.org/10.1080/15384047.2016.1235655

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation